These drugs have been used to treat type 2 diabetes for nearly two decades, with the first GLP-1 medication, exenatide, gaining FDA approval in 2005
Despite people with the PAM variant having higher circulating levels of GLP-1, we saw no evidence of higher biological activity
Patients with dementia had significant cognitive decline, which resulted in interference with independence in daily functioning
Lancet 2 (8571), 13001304
When there is stress at home at mealtime, when friendships are strained because it is uncomfortable to meet socially if food is involved, or when a partner, child, or parent thinks someone has developed very abnormal eating habits, these are all red flags